Arkis BioSciences has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo. According to Chad Seaver, CEO of Arkis BioSciences, the new catheter will be used for insertion into a ventricular cavity of the brain for external drainage of cerebrospinal fluid in patients with elevated intracranial pressure, intraventricular hemorrhage, or hydrocephalic shunt infections.
Panasonic PhotoMOS® Photovoltaic MOSFET High-Power Drivers
Adam-Tech Wire-to-Board Solutions